Other
Extremity
0
Pipeline Programs↗
6
Active Trials↗
4
Companies Involved↗
Extremity is an early-stage landscape with 0 programs across 4 companies. The most active players are Flex Pharma, Inc., Özge Mine Yilmaz, Neuraptive Therapeutics Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
25
clinical trials
Completed10 · 40%
Unknown status5 · 20%
Recruiting3 · 12%
Withdrawn2 · 8%
Not yet recruiting2 · 8%
Terminated1 · 4%
Other2 · 8%
Clinical Trials
Trial Activity
25 trials
Comparison of Upper Extremity Functions of Physiotherapy Students With Different Hand Preferences
Not yet recruiting·—·N/A·NCT07699068·42 enrolled
USG Brachial Plexus Block for Upper Extremity Surgery
Completed·—·N/A·NCT01993290·120 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)